CL - Colgate-Palmolive Company

NYSE - NYSE Delayed Price. Currency in USD
63.54
+0.83 (+1.32%)
At close: 4:00PM EST

63.54 0.00 (0.00%)
After hours: 5:56PM EST

Stock chart is not supported by your current browser
Previous Close62.71
Open63.00
Bid63.52 x 2200
Ask64.24 x 1000
Day's Range62.18 - 63.71
52 Week Range57.41 - 77.91
Volume3,903,546
Avg. Volume4,524,590
Market Cap55.11B
Beta (3Y Monthly)0.68
PE Ratio (TTM)26.30
EPS (TTM)2.42
Earnings DateJan 25, 2019
Forward Dividend & Yield1.68 (2.66%)
Ex-Dividend Date2018-10-18
1y Target Est62.98
Trade prices are not sourced from all markets
  • Recovery in Colgate-Palmolive Stock Could Be Short-Lived
    Market Realist4 days ago

    Recovery in Colgate-Palmolive Stock Could Be Short-Lived

    Colgate-Palmolive (CL) stock outperformed the broader markets in November and increased 6.7%. Colgate-Palmolive’s top line is projected to remain low during the fourth quarter, which reflects the negative impact from currency rates and challenging market conditions in China and Brazil. Analysts expect Colgate-Palmolive’s fourth-quarter EPS to decline on a year-over-year basis due to lower sales and weak margins.

  • Church & Dwight Stock Outperformed Its Peers
    Market Realist4 days ago

    Church & Dwight Stock Outperformed Its Peers

    Church & Dwight (CHD) stock has risen 32.7% on a YTD basis due to the company’s strong financial performance in 2018. The company’s top and bottom line have grown at a phenomenal rate in 2018. Other major consumer packaged goods companies including Colgate-Palmolive (CL), Kimberly-Clark (KMB), and Procter & Gamble (PG) have struggled to lift their sales and EPS growth rate. Church & Dwight sustained the momentum during the third quarter, while the stock rose 11.55 in November.

  • Which CPG Stocks Outperformed the Markets in November?
    Market Realist4 days ago

    Which CPG Stocks Outperformed the Markets in November?

    Shares of major CPG (consumer packaged goods) manufacturers showed a healthy recovery in November and outperformed the benchmark index (SPX). Shares of Church & Dwight (CHD), Clorox (CLX), Kimberly-Clark (KMB), Procter & Gamble (PG), and Colgate-Palmolive (CL) increased 11.5%, 11.6%, 10.6%, 6.6%, and 6.7%, respectively, in November. In comparison, the S&P 500 Index increased 1.8% during the same period.

  • Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
    Zacks4 days ago

    Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day

    Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day

  • Colgate (CL) Stock Down 14.3% YTD: What You Should Know
    Zacks4 days ago

    Colgate (CL) Stock Down 14.3% YTD: What You Should Know

    Colgate's (CL) dismal performance can be attributed to uncertain global markets. Also, a dismal sales trend is worrisome. However, the company's savings programs appear impressive.

  • Business Wire7 days ago

    Cresco Labs Begins Trading on the Canadian Securities Exchange Under Ticker Symbol ‘CL’

    “Today marks the beginning of an exciting new chapter in Cresco’s growth story,” said Charles Bachtell, CEO of Cresco Labs. Investors, media and other interested parties are invited to visit Cresco’s new Investors website at investors.crescolabs.com to view company information and request automated email alerts for future news and public filings. Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis with operations in six states (Illinois, Ohio, Pennsylvania, Nevada, California and Arizona) and approval pending for acquisitions in three more states (New York, Massachusetts, Maryland), the company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry.

  • InvestorPlace10 days ago

    Don’t Buy the Headlines or Clorox Stock at All Right Now

    Clorox (NYSE:CLX) stock has brought the company back in the headlines. After a 35% increase over the last six months, many wonder whether the time has come to buy Clorox stock. Household products stocks typically receive less attention than stocks like Amazon (NASDAQ:AMZN) or Tesla (NASDAQ:TSLA).

  • Why Wall Street Expects Downside in KMB Stock
    Market Realist11 days ago

    Why Wall Street Expects Downside in KMB Stock

    Wall Street analysts maintain a target price of $105.65 per share on Kimberly-Clark (KMB) stock, which indicates a downside of 8.5%, based on its closing price of $115.45 on November 27. Analysts expect Kimberly-Clark’s soft sales and weak margins to hurt its stock in the near term. Kimberly-Clark’s top line is expected to decline in the next couple of quarters, reflecting adverse currency rates and challenging market conditions in China.

  • Why KMB’s EPS Could Disappoint in the Near Term
    Market Realist11 days ago

    Why KMB’s EPS Could Disappoint in the Near Term

    Analysts expect Kimberly-Clark’s bottom line to take a hit from soft sales and cost headwinds in the near term. A higher tax rate is likely to affect the 2019 EPS growth rate. Analysts expect Kimberly-Clark to report adjusted earnings of $1.66 per share in the fourth quarter of 2018, which reflects year-over-year or YoY growth of 5.7%.

  • Financial Times12 days ago

    [$$] Unilever: Jope and glory

    Mr Polman also went on too much about sustainability for many people’s liking. Once the introductions are out of the way, Mr Jope should focus on ways to boost profits. Unilever has been a very good investment for much of Mr Polman’s tenure: total returns to shareholders have far outpaced the company’s global peers since he took over in 2009.

  • Why Kimberly-Clark’s Margins Are Expected to Decline
    Market Realist12 days ago

    Why Kimberly-Clark’s Margins Are Expected to Decline

    Kimberly-Clark’s (KMB) profit margins remained weak in the first nine months of 2018, and the trend is likely to continue as challenges persist, at least in the near term. Kimberly-Clark’s management expects inflation in commodities, including pulp and other raw materials, to continue to hurt its gross margins despite the benefits from a favorable mix, higher pricing, and cost savings. Weak gross margins are likely to hurt operating margins during the fourth quarter.

  • Why KMB’s Sales Are Projected to Fall in the Near Term
    Market Realist12 days ago

    Why KMB’s Sales Are Projected to Fall in the Near Term

    Wall Street expects Kimberly-Clark’s sales (KMB) to remain weak in the near term, at least over the next couple of quarters. Analysts expect Kimberly-Clark’s net sales to decline 2.7% in the fourth quarter of 2018. Meanwhile, its top line is forecast to fall 4.1% in the first quarter of 2019.

  • Will Sales and Cost Headwinds Stall the Recovery in KMB Stock?
    Market Realist12 days ago

    Will Sales and Cost Headwinds Stall the Recovery in KMB Stock?

    Shares of Kimberly-Clark (KMB) have increased 8.5% since the company reported better-than-expected third-quarter results on October 22. Kimberly-Clark’s third-quarter top and bottom lines came in ahead of analysts’ estimates, thanks to higher pricing, a favorable mix, a lower effective tax rate, and share repurchases.

  • New Strong Sell Stocks for November 27th
    Zacks13 days ago

    New Strong Sell Stocks for November 27th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

  • Why Is Colgate-Palmolive (CL) Down 3.2% Since Last Earnings Report?
    Zacks15 days ago

    Why Is Colgate-Palmolive (CL) Down 3.2% Since Last Earnings Report?

    Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • How CHD Has Outperformed Its Bigger Rivals This Year
    Market Realist20 days ago

    How CHD Has Outperformed Its Bigger Rivals This Year

    Church & Dwight (CHD) stock has had a phenomenal run so far this year. Church & Dwight’s focus on innovation, incremental sales from recent acquisitions, investments in its international business, and a balanced portfolio of value and premium products drove its top line. Strong sales growth and tax reforms have driven Church & Dwight’s bottom line, which has grown at a double-digit rate in the past four quarters and has outperformed Wall Street’s expectations.

  • 8 Best Stocks to Buy for the Holiday Spirit
    InvestorPlace21 days ago

    8 Best Stocks to Buy for the Holiday Spirit

    You might not think about it too much, but some of the best stocks to buy are also the most responsible. In a kill-or-be-killed environment, you don’t expect the investment sector to be conducive for a morality lesson. Various studies demonstrate that generous organizations can reap significant profits for their efforts.

  • Benzinga21 days ago

    Despite Down Monday, The Chart Of Colgate-Palmolive Looks Very Bullish Right Now

    The following stock has been highlighted by VantagePoint ai, an artificial intelligence platform that provides market forecasts 1-3 days in advance. Going forward, VantagePoint's two main indicators, a predicted moving average and predicted neural index, are both forecasting upside for the stock this week.

  • Hedge Funds Are Piling Into T-Mobile US, Inc. (TMUS)
    Insider Monkey22 days ago

    Hedge Funds Are Piling Into T-Mobile US, Inc. (TMUS)

    It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during October and average hedge fund losing about 3%. The Russell 2000, composed of smaller companies, performed even worse, trailing the S&P by about […]

  • What PG’s Target Price and Valuation Indicate
    Market Realist27 days ago

    What PG’s Target Price and Valuation Indicate

    The majority of Wall Street analysts providing recommendations on Procter & Gamble (PG) stock maintain a neutral outlook. Wall Street expects near-term cost headwinds and unfavorable currency rates to hurt the company’s net sales and EPS growth rate. However, innovation-driven products, productivity savings, and a lower effective tax rate are projected to support the top and bottom lines.

  • PG Continues to Beat EPS Estimates, but Growth Rate Slows
    Market Realist27 days ago

    PG Continues to Beat EPS Estimates, but Growth Rate Slows

    Procter & Gamble (PG) has impressed with its earnings despite facing strong sales and margin headwinds in the recent past. The company outperformed analysts’ estimates in the past 14 quarters with an average positive surprise of 4.3%, which is impressive. Focus on productivity and cost savings, a considerable decline in the effective tax rate, and share repurchases have helped the company to surpass analysts’ expectations.

  • Why PG’s Margins Could Continue to Fall in the Near Term
    Market Realist28 days ago

    Why PG’s Margins Could Continue to Fall in the Near Term

    Procter & Gamble (PG) announced price increases across several product categories aimed at offsetting the adverse impact from the foreign exchange rate and continued inflation in commodities. However, we expect the company’s margins to remain weak and continue to slide, at least in the near term.

  • Why PG’s Top Line Could Remain Weak in the Near Term
    Market Realist28 days ago

    Why PG’s Top Line Could Remain Weak in the Near Term

    PG Stock Is Up 15.2% since Q1 Results: Will Uptrend Continue? The company’s organic sales came in better than what analysts expected and rose 4% thanks to the improvement in volumes across all business segments and the favorable mix in the beauty segment. Despite strong organic sales growth, Procter & Gamble’s net sales growth remained low, reflecting the adverse impact from the foreign exchange rate.